Invasive assessment of the coronary circulation: Intravascular ultrasound and Doppler

British Journal of Clinical Pharmacology

Volumn 53, Issue 6, 2002, Pages 561-575

  Newby, David E ^a   Fox, Keith A A ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT;

ANGIOCARDIOGRAPHY; ARTERY RESISTANCE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BALLOON CATHETER; BOLUS INJECTION; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY SINUS; DOPPLER FLOWMETRY; DRUG DELIVERY SYSTEM; FUNCTIONAL ASSESSMENT; HUMAN; INTRAVASCULAR ULTRASOUND; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; REMISSION; REPRODUCIBILITY; RESTENOSIS; REVIEW; THERMODILUTION; VASCULAR ACCESS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY BLOOD VESSEL; DOPPLER ECHOCARDIOGRAPHY; DRUG ADMINISTRATION ROUTE; ENDOSCOPIC ECHOGRAPHY; HEART CATHETERIZATION; INSTRUMENTATION; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANTILIPEMIC AGENTS; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG ADMINISTRATION ROUTES; ECHOCARDIOGRAPHY, DOPPLER; ENDOTHELIUM, VASCULAR; HEART CATHETERIZATION; HUMAN; SUPPORT, NON-U.S. GOV'T; THERMODILUTION; ULTRASONOGRAPHY, INTERVENTIONAL; HUMANS;

EID: 0035987186     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2002.01582.x     Document Type: Review

References (136)

1. Computerised assessment of coronary lumen and atherosclerotic plaque dimensions in three-dimensional intravascular ultrasound correlated with histomorphometry
2. ECG-gated three-dimensional intravascular ultrasound feasibility and reproducibility of the automated analysis of coronary artery lumen and atherosclerotic plaque dimensions in humans
3. Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin
4. Rationale for a postintervention continuum of care: Insights from intravascular ultrasound
5. Modified heparin-bonded catheter for cannulation of the coronary sinus from the femoral vein
6. Cannulation of the coronary sinus via the femoral vein - A new technique
7. Substance P dilates epicardial coronary arteries and increases coronary blood flow in humans
8. Impaired coronary tissue plasminigen activator release is associated with coronary atherosclerosis and cigarette smoking: Direct link between endothelial dysfunction and atherothrombosis
9. Intracoronary infusions and the assessment of coronary blood flow in clinical studies
10. Heterogenous vasomotor responses of coronary conduit and resistance vessels in hypertension
11. Determinants of coronary remodeling in transplant coronary disease
12. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic human coronary arteries
13. Angiotensin-converting enzyme inhibition with quinapril improves endothelial dysfunction in patients with coronary heart disease
14. Coronary vascular nitric oxide activity in hypertension and hypercholesterolaemia
15. Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: Effects of angiotensin-converting enzyme inhibitors
16. Bradykinin-induced vasodilatation is impaired at the atherosclerotic site but is preserved at the spastic site of human coronary arteries in vivo
17. Endothelium-dependent dilator response to substance P in patients with coronary spastic angina
18. Large coronary arteries in humans are responsive to changing blood flow: An endothelium-dependent mechanism that fails in patients with atherosclerosis
19. Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans
20. Intracoronary Doppler assessment of moderate coronary artery disease
21. Recombinant gene expression in vivo within endothelial cells of the artery wall
22. Site-specific gene expression in vivo by direct gene transfer into the arterial wall
23. Intracoronary heparin delivery in humans
24. Efficacy of low-molecular-weight heparin delivery with the Dispatch catheter following balloon angioplasty in the rabbit iliac artery
25. Treatment of thrombotic saphenous vein bypass grafts using local urokinase infusion therapy with the Dispatch catheter
26. Local delivery of heparin to balloon angioplasty sites with a new angiotherapy catheter
27. Local urokinase delivery with the channel balloon
28. Magnetic resonance imaging permits in vivo monitoring of catheter-based vascular gene delivery
29. Local delivery of C-myb antisense oligonucleotides during balloon angioplasty
30. Local drug delivery with porous balloons in the rabbit
31. Endoluminal local delivery of PCN/cdc2 antisense oligonucleotides by porous balloon catheter does not affect neointima formation or vessel size in the pig coronary artery model of postangioplasty restenosis
32. Pharmacokinetics and tissue localisation of antisense oligonucleotides in balloon-injured pig coronary arteries after local delivery with an iontophoretic balloon catheter
33. Localised delivery of heparin to angioplasty sites with iontophoresis
34. Infiltrator angioplasty balloon catheter
35. Intramural drug delivery by direct injection within the arterial wall
36. Localised arterial wall drug delivery from a polymer coated removable metallic stent: Kinetics, distribution and bioactivity of forskolin
37. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study
38. Novel drug-delivery stent: Intravascular ultrasound observations from the first human experience with the QP2-eluting polymer stent system
39. Local intraluminal infusion of biodegradeable polymeric nanoparticles: A novel approach for prolonged drug delivery after balloon angioplasty
40. Sustained local drug delivery to the arterial wall via biodegradable microspheres
41. Determinants of coronary blood flow after thrombolytic administration
42. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs
43. Slow coronary flow: A distinct angiographic subgroup in syndrome X
44. Blood flow assessment with intravascular ultrasound catheters: The ideal tool for simultaneous assessment of the coronary haemodynamics and vessel wall?
45. Flow estimation using an intravascular imaging catheter
46. Measurement of coronary sinus blood flow by continuous thermodilution in man
47. Computerised system for the continuous measurement of azygos venous blood flow
48. Comparable potent coronary vasoconstrictor effects of endothelin-1 and big endothelin-1 in humans
49. Evaluation of the thermodilution technique for measuring coronary sinus blood flow
50. Assessment of the human coronary circulation using a Doppler catheter
51. Safety of intracoronary Doppler flow measurement
52. Variability in the analysis of coronary angiograms
53. Does visual interpretation of the coronary angiogram predict the physiologic importance of a coronary stenosis?
54. The safety of intracoronary ultrasound: A multicentre survey of 2207 examinations
55. Intravascular ultrasound imaging of angiographically normal coronary artery segments in patients with coronary artery disease
56. Measurement by intravascular ultrasound of in vivo arterial distensibility within atherosclerotic lesions
57. Assessment of coronary conductance and resistance vessel reactivity in response to nitroglycerin, ergonovine and adenosine: In vivo studies with simultaneous intravascular two-dimensional and Doppler ultrasound
58. Intracoronary ultrasound: Current state of the art
59. Clinical application and image interpretation in intracoronary ultrasound
60. Intravascular ultrasound imaging of angiographically normal coronary arteries: A prospective study in vivo
61. Acute plaque rupture and myocardial stunning in patient with normal coronary arteriography
62. Value of intracoronary ultrasound and Doppler in the differentiation of angiographically normal coronary arteries: A prospective study in patients with angina pectoris
63. Compensatory enlargement of human atherosclerotic coronary arteries
64. Coronary artery remodelling in atherosclerotic disease: An intravascular ultrasonic study in vivo
65. Detection of intralesional calcium by intracoronary ultrasound depends on the histological pattern
66. Differences in the morphology of unstable and stable coronary lesions and their impact on the mechanisms of angioplasty
67. Coronary artery calcium in acute coronary syndromes
68. Intracoronary ultrasound imaging: Correlation of plaque morphology with angiography, clinical syndrome and procedural results in patients undergoing coronary angioplasty
69. Characterization of coronary atherosclerotic morphology by spectral analysis of radiofrequency signal: In vitro intravascular ultrasound study with histological and radiological validation
70. Electrocardiogram-gated intravascular ultrasound image acquisition after coronary stent deployment facilitates on-line three-dimensional reconstruction and automated lumen quantification
71. Intravascular ultrasound versus angiography for measurement of luminal diameters in normal and diseased coronary arteries
72. Effects of arterial remodelling on the degree of discrepancy between quantitative coronary angiography and ultrasound imaging in determining true vessel dimensions
73. Comparison of quantitative angiographically derived and measured translesion pressure and flow velocity in coronary artery disease
74. Characterization of changes in coronary blood flow during the first six seconds after intracoronary contrast injection
75. Simultaneous intracoronary ultrasound and Doppler flow studies distinguish flow-mediated from receptor-mediated endothelial responses
76. Assessment of flow-dependent dilatation in the human conductance coronary artery using a simultaneous intravascular two-dimensional and Doppler ultrasound system
77. Influence of intimal thickening on coronary blood flow responses in orthotopic heart transplant recipients
78. Combined physiologic and anatomic assessment of percutaneous revascularisation using a Doppler guidewire and ultrasound catheter
79. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B
80. Can life style changes reverse coronary heart disease? The Lifestyle Heart Trial
81. Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis
82. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity
83. Analysis of coronary blood flow velocity dynamics in angiographically normal and stenosed arteries before and after endolumen enlargement by angioplasty
84. Correlation of pharmacological Tc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses
85. Intracoronary Doppler guide wire versus stress single-photon emission computed tomographic thallium-201 imaging in assessment of intermediate coronary stenoses
86. Validation of Doppler Flowire for measurement of coronary flow reserve in humans
87. Simultaneous coronary pressure and flow velocity measurements in humans
88. Long-term reproducibility of coronary flow velocity measurements in patients with coronary artery disease
89. Sensitivity and reproducibility of the instantaneous hyperemic flow versus pressure slope index compared to coronary flow reserve for the assessment of stenosis severity
90. Assessment of short-, medium- and long-term variations in arterial dimesions from computer-assisted quantification of coronary cineangiograms
91. Automated quantitative coronary arteriography: Morphologic and physiologic validation in vivo of a rapid digital angiographic method
92. The effect of angiographic technique and image quality on the reproducibility of measurement of carotid stenosis and assessment of plaque surface morphology
93. Contrast-enhanced intravascular ultrasound: Validation of a new technique for delineation of the vessel wall boundary
94. Variability in the measurement of intracoronary ultrasound images: Implications for the identification of atherosclerotic plaque regression
95. Volumetric intracoronary ultrasound: Methods and validation
96. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension
97. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus
98. Coronary reserve and exercise ECG in patients with chest pain and normal coronary angiograms
99. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis
100. Decreased coronary reserve. A mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries
101. Vasodilator reserve. A functional assessment of coronary health
102. Nitric oxide activity in the human coronary circulation: Impact of risk factors for coronary atherosclerosis
103. Role of endogenous bradykinin in human coronary vasomotor control
104. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease
105. Beneficial effect of cholesterol lowering therapy on coronary endothelium-dependent vasorelaxation in hypercholesterolaemic patients
106. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients
107. Modulation of coronary vasomotor tone in humans
108. Discordant epicardial and microvascular endothelial responses in heart transplant recipients early after transplantation
109. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women
110. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine
111. Effect of L-arginine on coronary endothelial function in cardiac transplant recipients
112. Intracoronary infusion of reduced glutathione improves endothelial vasomotor responses to acetylcholine in human coronary circulation
113. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia
114. Estimation of the secretion rate of atrial natriuretic peptide from the coronary sinus in coronary artery disease
115. Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris
116. Coronary hemodynamics and myocardial metabolism in patients with syndrome X: Response to pacing stress
117. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)
118. Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS])
119. Ultrasound and lipoproteins as predictors of lipid-rich, rupture-prone plaques in the carotid artery
120. Morphology of vulnerable coronary plaque: Insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome
121. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque Volume and composition in patients with coronary artery disease
122. Accelerated coronary vascular disease in the heart transplant patient: Coronary angiographic findings
123. Intraindividual variability of cardiac allograft vasculopathy as assessed by intravascular ultrasound
124. Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound
125. Coronary atherosclerotic wall thickening and vascular reactivity in humans
126. Functional significance of intimal thickening as detected by intravascular ultrasound early and late after cardiac transplantation
127. Three dimensional intravascular ultrasonic assessment of the local mechanism of restenosis after balloon angioplasty
128. Local intracoronary administration of antisense digonucleotide against c-myc for the prevention of in-stent restonosis
129. Local drug delivery systems and prevention of restenosis
130. Optimal techniques for arterial gene transfer
131. Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER Study)
132. Intravascular ultrasound: Novel pathophysiological insights and current clinical applications
133. New developments in the detection of vulnerable plaque
134. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells
135. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging
136. In vivo evaluation of an intravascular receiver coil for MRI at 1.0 Tesla